Veru, Inc. (VERU)
2.12
0.00 (0.00%)
USD |
NASDAQ |
Nov 13, 16:00
2.12
0.00 (0.00%)
After-Hours: 19:59
Veru Enterprise Value : 13.04M for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 13.04M |
| November 11, 2026 | 13.38M |
| November 10, 2026 | 13.04M |
| November 09, 2026 | 14.23M |
| November 06, 2026 | 13.04M |
| November 05, 2026 | 12.02M |
| November 04, 2026 | 14.40M |
| November 03, 2026 | 13.72M |
| November 02, 2026 | 13.72M |
| October 30, 2026 | 14.23M |
| October 29, 2026 | 14.91M |
| October 28, 2026 | 15.60M |
| October 27, 2026 | 15.77M |
| October 26, 2026 | 14.57M |
| October 23, 2026 | 15.08M |
| October 22, 2026 | 15.94M |
| October 21, 2026 | 16.11M |
| October 20, 2026 | 17.47M |
| October 19, 2026 | 16.28M |
| October 16, 2026 | 16.11M |
| October 15, 2026 | 18.49M |
| October 14, 2026 | 13.21M |
| October 13, 2026 | 14.23M |
| October 12, 2026 | 17.90M |
| October 09, 2026 | 18.84M |
| Date | Value |
|---|---|
| October 08, 2026 | 18.15M |
| October 07, 2026 | 18.84M |
| October 06, 2026 | 19.01M |
| October 05, 2026 | 20.37M |
| October 02, 2026 | 19.69M |
| October 01, 2026 | 20.20M |
| September 30, 2026 | 22.25M |
| September 29, 2026 | 20.54M |
| September 28, 2026 | 19.94M |
| September 25, 2026 | 20.20M |
| September 24, 2026 | 19.69M |
| September 23, 2026 | 18.84M |
| September 22, 2026 | 19.52M |
| September 21, 2026 | 18.49M |
| September 18, 2026 | 17.98M |
| September 17, 2026 | 17.64M |
| September 16, 2026 | 16.45M |
| September 15, 2026 | 16.79M |
| September 14, 2026 | 16.79M |
| September 11, 2026 | 18.49M |
| September 10, 2026 | 19.52M |
| September 09, 2026 | 19.18M |
| September 08, 2026 | 20.88M |
| September 04, 2026 | 21.90M |
| September 03, 2026 | 22.07M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.798B |
| Corcept Therapeutics, Inc. | 7.700B |
| Johnson & Johnson | 709.89B |
| Eli Lilly & Co. | 1.388T |
| Lexicon Pharmaceuticals, Inc. | 686.19M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.988M |
| Total Expenses (Quarterly) | 6.988M |
| EPS Diluted (Quarterly) | -0.3032 |
| Earnings Yield | -28.82% |
| Normalized Earnings Yield | -35.09 |